As is well known, CIH in OSA patients can cause oxidative stress, systemic inflammation, and NF-κB-dependent inflammatory pathway activation [33,76], which is the potential pathogenesis of complications such as diabetes mellitus and cardiovascular disorders [77,78]. This evidence concerns the gene NFKB1 and diabetes mellitus.